Journal of Experimental Therapeutics and Oncology
SJR0.108
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2023 | — | — | 0.108 | Q4 | 12.6% | |
| 2022 | — | — | 0.107 | Q4 | 16.3% | |
| 2021 | — | — | 0.230 | Q4 | 43.3% | |
| 2020 | — | — | 0.163 | Q4 | 26.7% | |
| 2019 | — | — | 0.231 | Q3 | 43.8% | |
| 2018 | — | — | 0.239 | Q3 | 42.1% | |
Impact history
Annual SJR and Impact Factor trend.
SJR
Journal record
eISSN
1533-869X
ISSN
1359-4117
region
Northern America
coverage
1996, 2002-2020